- Home
- BOOT vs LGND Comparison
BOOT vs LGND Comparison
Compare BOOT & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BOOT | LGND |
|---|---|---|
| Founded | 1978 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Clothing/Shoe/Accessory Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.5B | 3.7B |
| IPO Year | 2014 | 1997 |
Fundamental Metrics
Financial Performance| Metric | BOOT | LGND |
|---|---|---|
| Price | $162.02 | $281.50 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 12 | 7 |
| Target Price | $223.09 | ★ $256.29 |
| AVG Volume (30 Days) | ★ 730.2K | 200.4K |
| Earning Date | 05-13-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 25.00 | ★ 2886.36 |
| EPS | ★ 2.29 | 1.63 |
| Revenue | ★ $776,854,000.00 | $141,102,000.00 |
| Revenue This Year | $19.98 | $1.25 |
| Revenue Next Year | $13.91 | $19.41 |
| P/E Ratio | ★ $70.66 | $171.89 |
| Revenue Growth | 14.59 | ★ 29.48 |
| 52 Week Low | $133.18 | $158.52 |
| 52 Week High | $210.25 | $326.63 |
Technical Indicators
Market Signals| Indicator | BOOT | LGND |
|---|---|---|
| Relative Strength Index (RSI) | 50.33 | 41.47 |
| Support Level | $153.59 | $181.43 |
| Resistance Level | $170.91 | $322.06 |
| Average True Range (ATR) | 6.41 | 10.01 |
| MACD | 0.18 | -1.62 |
| Stochastic Oscillator | 25.67 | 3.40 |
Price Performance
Historical ComparisonAbout BOOT Boot Barn Holdings Inc.
Boot Barn Holdings Inc operates specialty retail stores that sell western and work boots and related apparel and accessories. The Company operates retail locations throughout the U.S. and sells its merchandise via the Internet. The Company operates a total of approximately 539 stores in 49 states. All stores operated under the Boot Barn name.
About LGND Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.